Evidence map›Paper›PMID 32290257›Full record

ReviewCells2020

Noninvasive Tracking of Hematopoietic Stem Cells in a Bone Marrow Transplant Model.

Fernando A Oliveira, Mariana P Nucci, Igor S Filgueiras, João M Ferreira, Leopoldo P Nucci, Javier B Mamani, Fernando Alvieri, Lucas E B Souza, Gabriel N A Rego, Andrea T Kondo and 2 more

Abstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Current advancements in nanotechnology for stem cells.International journal of surgery (London, England) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Theranostic Diagnostics.Results and problems in cell differentiation · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19.Chembiochem : a European journal of chemical biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fernando A OliveiraHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Mariana P NucciLIM44-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-903, Brazil.
Igor S FilgueirasHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
João M FerreiraHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Leopoldo P NucciCentro Universitário do Planalto Central, Brasília 72445-020, DF, Brazil.
Javier B MamaniHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Fernando AlvieriHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Lucas E B SouzaFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto 14049-900, SP, Brazil.
Gabriel N A RegoHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Andrea T KondoHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Nelson HamerschlakHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Lionel F GamarraHospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.ORCID 0000-0002-3910-0047

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hematopoietic stem cell engraftment depends on adequate cell numbers, their homing, and the subsequent short and long-term engraftment of these cells in the niche. We performed a systematic review of the methods employed to track hematopoietic reconstitution using molecular imaging. We searched articles indexed, published prior to January 2020, in PubMed, Cochrane, and Scopus with the following keyword sequences: (Hematopoietic Stem Cell OR Hematopoietic Progenitor Cell) AND (Tracking OR Homing) AND (Transplantation). Of 2191 articles identified, only 21 articles were included in this review, after screening and eligibility assessment. The cell source was in the majority of bone marrow from mice (43%), followed by the umbilical cord from humans (33%). The labeling agent had the follow distribution between the selected studies: 14% nanoparticle, 29% radioisotope, 19% fluorophore, 19% luciferase, and 19% animal transgenic. The type of graft used in the studies was 57% allogeneic, 38% xenogeneic, and 5% autologous, being the HSC receptor: 57% mice, 9% rat, 19% fish, 5% for dog, porcine and salamander. The imaging technique used in the HSC tracking had the following distribution between studies: Positron emission tomography/single-photon emission computed tomography 29%, bioluminescence 33%, fluorescence 19%, magnetic resonance imaging 14%, and near-infrared fluorescence imaging 5%. The efficiency of the graft was evaluated in 61% of the selected studies, and before one month of implantation, the cell renewal was very low (less than 20%), but after three months, the efficiency was more than 50%, mainly in the allogeneic graft. In conclusion, our review showed an increase in using noninvasive imaging techniques in HSC tracking using the bone marrow transplant model. However, successful transplantation depends on the formation of engraftment, and the functionality of cells after the graft, aspects that are poorly explored and that have high relevance for clinical analysis.

Indexed as

AnimalsBone Marrow TransplantationHematopoietic Stem CellsHumansMiceTransfectionbioluminescencehematopoietic stem cellhomingmagnetic resonance imagemolecular imagingnanoparticlenear-infrared fluorescence imagenoninvasive imagingtracking

Identifiers

PMID32290257
PMCPMC7226958

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.